Correlation Between Tarsus Pharmaceuticals and Entheon Biomedical

Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Entheon Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Entheon Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tarsus Pharmaceuticals and Entheon Biomedical Corp, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Entheon Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Entheon Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Entheon Biomedical.

Diversification Opportunities for Tarsus Pharmaceuticals and Entheon Biomedical

0.46

Correlation Coefficient

Tarsus Pharmaceuticals  Entheon Biomedical

Very weak diversification

The 3 months correlation between Tarsus and Entheon is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Entheon Biomedical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entheon Biomedical Corp and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Entheon Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entheon Biomedical Corp has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Entheon Biomedical go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Entheon Biomedical

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 6.72 times less return on investment than Entheon Biomedical. But when comparing it to its historical volatility, Tarsus Pharmaceuticals is 13.2 times less risky than Entheon Biomedical. It trades about 0.32 of its potential returns per unit of risk. Entheon Biomedical Corp is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  5.60  in Entheon Biomedical Corp on September 29, 2024 and sell it today you would earn a total of  11.40  from holding Entheon Biomedical Corp or generate 203.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.44%
Values	Daily Returns

Tarsus Pharmaceuticals  vs.  Entheon Biomedical Corp

Tarsus Pharmaceuticals

Risk-Adjusted Performance

24 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Entheon Biomedical Corp

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Entheon Biomedical Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental drivers, Entheon Biomedical reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Tarsus Pharmaceuticals and Entheon Biomedical

The main advantage of trading using opposite Tarsus Pharmaceuticals and Entheon Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Entheon Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entheon Biomedical will offset losses from the drop in Entheon Biomedical's long position.

The idea behind Tarsus Pharmaceuticals and Entheon Biomedical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.